SLNO β€” SOLENO THERAPEUTICS INC

Ownership history in MAPLELANE CAPITAL, LLC  Β·  8 quarters on record

This page tracks every 13F SEC filing in which MAPLELANE CAPITAL, LLC reported a position in SOLENO THERAPEUTICS INC (SLNO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.07% (2024 Q3)
πŸ“Š Avg. % of fund
0.03%
πŸ“… First filed
2023 Q3
πŸ“… Last filed
2025 Q3
⏱ Quarters held
8

Position Intelligence

MAPLELANE CAPITAL, LLC Γ— SLNO AI Analytics

πŸ“ˆ MAPLELANE CAPITAL, LLC outperformed the S&P 500 by +18.1% annually on this SLNO position. Average cost basis: $44.95. Maximum drawdown during holding period: –11.0%.

πŸ“ˆ Position Alpha vs SPY
+18.1%
annualised excess return

πŸ”₯ Exceptional β€” beat the S&P 500 by 18.1% per year on this position.
6 quarters analyzed

πŸ’° Entry Quality
$44.95
+50.4% vs current ($67.60)

Best entry: $44.95 (2024 Q4)  Β·  Worst: $44.95 (2024 Q4)

πŸ›‘οΈ Drawdown Resilience
–11.0%
max drawdown while held

πŸ’Ž No drawdown exceeding 20% during the holding period β€” exceptionally stable.

πŸ’ͺ Fund Conviction
50%
buy-side decisions

2 adds Β· 2 trims. Bought during 0 of 2 down-price quarters. πŸ“ˆ More buys than sells across the holding period.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.02% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    SLNO price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 8 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 13,001 -2,158 -14.2% 0.02% $879K $67.60
2024 Q4 ADDED 15,159 +5,318 +54.0% 0.02% $681K $44.95
2024 Q4 REDUCED 9,841 -15,159 -60.6% 0.01% $442K $44.95
2024 Q3 UNCHANGED 25,000 β€” 0% 0.07% $1.3M $50.49
2024 Q2 UNCHANGED 25,000 β€” 0% 0.03% $1.0M $40.80
2024 Q1 UNCHANGED 25,000 β€” 0% 0.03% $1.1M $42.80
2023 Q4 UNCHANGED 25,000 β€” 0% 0.05% $1.0M $40.25
2023 Q3 INITIATED 25,000 β€” β€” 0.04% $738K β€”

🏒 Other funds also holding SLNO

As of 2025 Q4 β€” sorted by position size

Ally Bridge Group (NY) LLC 3Y 8.1% GREAT POINT PARTNERS LLC 3Y 7Y 6.0% Buckley Capital Advisors, LLC 4.86% Seven Fleet Capital Management LP 4.58% Commodore Capital LP 3Y 3.7% Artia Global Partners LP 3Y 3.5% Catalio Capital Management, LP 2.95% Vivo Capital, LLC 3Y 7Y 2.68% Brummer Multi-Strategy AB 2.45% KINGDON CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 2.2%
← Back to MAPLELANE CAPITAL, LLC Holdings